Melting point	110-112 ºC
Water Solubility	1480 g/L (20 ºC)
Flash point	136 ºC
Density	1.07

SDS/MSDS	S24/25

Source	SDS/MSDS Samples
Alfa-Aesar	View & Download
Sigma-Aldrich	View & Download
TCI	View & Download

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products.Sarah Nicolai et al.Science immunology, 5(43) (2020-01-05) Electrochemical characterization of liquid phase exfoliated two-dimensional layers of molybdenum disulfide.Andrew Winchester et al.ACS applied materials & interfaces, 6(3), 2125-2130 (2014-01-22) Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives.S Sato et al.Chemical & pharmaceutical bulletin, 46(5), 831-836 (1998-06-11) Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders.María Rincón et al.Nanomaterials (Basel, Switzerland), 8(12) (2018-12-14) Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin.Vijay Krishna Rachakonda et al.Pharmaceutical research, 25(11), 2697-2704 (2008-08-07) Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery.H Sasaki et al.The Journal of pharmacy and pharmacology, 42(3), 196-199 (1990-03-01) Comparative studies on the anticonvulsant activity of lipophilic derivatives of gamma-aminobutyric acid and 2-pyrrolidinone in mice.J Nakamura et al.Journal of pharmacobio-dynamics, 14(1), 1-8 (1991-01-01) Aminoborohydrides. 11. Facile reduction of N-alkyl lactams to the corresponding amines using lithium aminoborohydrides.J M Flaniken et al.Organic letters, 1(5), 799-801 (2005-08-25) In vitro permeation study of hinokitiol: effects of vehicles and enhancers.Hyang Hee Joo et al.Drug delivery, 15(1), 19-22 (2008-01-17) Design of improved permeation enhancers for transdermal drug delivery.Srinivas S Godavarthy et al.Journal of pharmaceutical sciences, 98(11), 4085-4099 (2009-08-22)

Remarks